Literature DB >> 23278664

Cortical pathology in multiple sclerosis: experimental approaches to studies on the mechanisms of demyelination and remyelination.

S M Staugaitis1, A Chang, B D Trapp.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of unknown etiology that can involve all parts of the central nervous system and is unique to humans. Therefore, analysis of human tissue is critical for generating hypotheses for testing in animal or in vitro models and for validating research findings from these experimental models. This article reviews data on demyelination and remyelination in the cerebral cortex. We show that research on cerebral cortical demyelination and remyelination in appropriately processed postmortem MS tissues provides innovative approaches for developing hypotheses for studies on the pathogenesis MS lesions including identification of targets for therapy at early stages of the disease.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23278664     DOI: 10.1111/ane.12041

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  9 in total

Review 1.  Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.

Authors:  Ranjan Dutta
Journal:  Mult Scler       Date:  2013-09       Impact factor: 6.312

Review 2.  Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.

Authors:  Juan Xiao; Rongbing Yang; Sangita Biswas; Yunhua Zhu; Xin Qin; Min Zhang; Lihong Zhai; Yi Luo; Xiaoming He; Chun Mao; Wenbin Deng
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

3.  Profiles of cortical inflammation in multiple sclerosis by 11C-PBR28 MR-PET and 7 Tesla imaging.

Authors:  Elena Herranz; Céline Louapre; Constantina Andrada Treaba; Sindhuja T Govindarajan; Russell Ouellette; Gabriel Mangeat; Marco L Loggia; Julien Cohen-Adad; Eric C Klawiter; Jacob A Sloane; Caterina Mainero
Journal:  Mult Scler       Date:  2019-08-01       Impact factor: 5.855

4.  Gray and White Matter Demyelination and Remyelination Detected with Multimodal Quantitative MRI Analysis at 11.7T in a Chronic Mouse Model of Multiple Sclerosis.

Authors:  Alexandra Petiet; Marie-Stéphane Aigrot; Bruno Stankoff
Journal:  Front Neurosci       Date:  2016-10-27       Impact factor: 4.677

Review 5.  Targeting Phosphodiesterases-Towards a Tailor-Made Approach in Multiple Sclerosis Treatment.

Authors:  Melissa Schepers; Assia Tiane; Dean Paes; Selien Sanchez; Ben Rombaut; Elisabeth Piccart; Bart P F Rutten; Bert Brône; Niels Hellings; Jos Prickaerts; Tim Vanmierlo
Journal:  Front Immunol       Date:  2019-07-24       Impact factor: 7.561

Review 6.  Gray matters in multiple sclerosis: cognitive impairment and structural MRI.

Authors:  Silvia Messina; Francesco Patti
Journal:  Mult Scler Int       Date:  2014-01-22

7.  Imaging and clinical properties of inflammatory demyelinating pseudotumor in the spinal cord.

Authors:  Ying Wang; Min Wang; Hui Liang; Quntao Yu; Zhihui Yan; Min Kong
Journal:  Neural Regen Res       Date:  2013-09-15       Impact factor: 5.135

8.  Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase.

Authors:  Carlos E Pedraza; Christopher Taylor; Albertina Pereira; Michelle Seng; Chui-Se Tham; Michal Izrael; Michael Webb
Journal:  ASN Neuro       Date:  2014-06-25       Impact factor: 4.146

Review 9.  Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis.

Authors:  Jorge Matías-Guiu; Jordi A Matías-Guiu; Paloma Montero-Escribano; Juan A Barcia; Alejandro A Canales-Aguirre; Juan C Mateos-Diaz; Ulises Gómez-Pinedo
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.